Skip to main content
Lotus Pharm logo

Lotus Pharm — Investor Relations & Filings

Ticker · 1795 ISIN · TW0001795003 LEI · 984500BEECDBC04KP716 TW Manufacturing
Filings indexed 2,730 across all filing types
Latest filing 2024-06-20 Regulatory Filings
Country TW Taiwan
Listing TW 1795

About Lotus Pharm

http://www.lotuspharm.com.tw

Lotus Pharmaceutical Co., Ltd. is a global specialty organization focused on the development, manufacturing, and commercialization of high-barrier generic and specialty medicines. The company specializes in complex generics, with a primary focus on oncology, immunology, and addiction treatment. Its portfolio includes technically demanding products such as Lenalidomide, Suboxone, Nintedanib, and Vinorelbine, as well as an advancing pipeline of biosimilars and 505(b)(2) oncology candidates. Utilizing an integrated R&D and manufacturing platform, the company executes a "2x2" growth strategy centered on dual market expansion and product diversification. Its commercial footprint spans over 90 markets globally, maintaining a strong presence in the Asia-Pacific region and the United States. The company prioritizes high technical entry barriers and cost-effective therapeutic solutions to improve global patient access to essential medications.

Recent filings

Filing Released Lang Actions
113年年報及股東會資料 — 2024_1795_20240613F13.pdf
Regulatory Filings
2024-06-20 Chinese
113年年報及股東會資料 — 2024_1795_20240613F02.pdf
Regulatory Filings
2024-06-20 Chinese
113年年報及股東會資料 — 2024_1795_20240613FE1.pdf
Regulatory Filings
2024-06-20 Chinese
113年年報及股東會資料 — 2024_1795_20240613F05.pdf
AGM Information Classification · 95% confidence The document is titled as the minutes of the Annual General Meeting (AGM) of 美時化學製藥股份有限公司 for the year 113 (2024). It includes details such as the meeting date, location, attendance, chairman, and agenda items including the 112 fiscal year business and financial report and the audit committee's report. The content is consistent with typical AGM minutes, including voting results and shareholder attendance. There is no indication that this is the full annual report (10-K) or audit report (AR) itself, but rather the official record of the AGM proceedings. Therefore, the document fits the category of AGM Information (AGM-R). The document length is substantial (15,000 characters), indicating it is not a brief announcement or notice but the full meeting minutes.
2024-06-20 Chinese
113年年報及股東會資料 — 2024_1795_20240613F01.pdf
AGM Information Classification · 95% confidence The document is a detailed notice and proxy form related to a company's Annual General Meeting (AGM). It includes information about the meeting date, location, agenda items such as approval of the annual business report and financial statements, dividend distribution, election of directors, and other shareholder meeting procedures. It also contains instructions for proxy voting and electronic voting. There is no actual financial data or report content included, only meeting and voting information. Therefore, this document fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM or related notices.
2024-06-20 Chinese
功能性委員會成員
Board/Management Information Classification · 90% confidence The document is very short (280 characters) and contains a table listing company code, company name, establishment date, and member names with expertise. There is no financial data, no report content, no announcement of voting results, no management changes, no financial statements, or any other detailed report content. It appears to be a simple disclosure of board or committee members and their expertise, which aligns with Board/Management Information filings. Given the brevity and content, it is not a full report but a management or board information disclosure.
2024-06-13 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.